This finding was validated through immunohistochemical analysis showing increased MAT1A protein abundance in drug treated tumors (Figure 3B) compared to untreated controls (Figure 3A) and patient bladder tumor tissue sections having received neoadjuvant chemotherapy (Figure 3D,E). The gene discussed is MAT1A; the disease is urinary bladder neoplasm.